Craft

Guizhou Sanli Pharmaceutical

Stock Price

¥14.1

2024-10-29

Market Capitalization

¥5.7 B

2024-10-29

Revenue

¥2.1 B

FY, 2024

Guizhou Sanli Pharmaceutical Summary

Company Summary

Overview
Guizhou Sanli Pharmaceutical (贵州三力制药股份有限公) researches and develops medicinal products. It focuses on pediatrics, the respiratory systems, cardio cerebral vascular, gastroenterology, and other fields. The company offers soft and hard capsules, sprays, and other medicines.
Type
Public
Status
Active
Founded
1995
HQ
An Shun Shi, CN | view all locations
Website
http://www.gz-sanli.com
Cybersecurity rating
Sectors

LocationsView all

1 location detected

  • An Shun Shi, Gui Zhou Sheng HQ

    China

    F87G+HH4, Xing Ye Dong Lu, Ping Ba Qu

Guizhou Sanli Pharmaceutical Financials

Summary Financials

Revenue (Q3, 2025)
¥332.5M
Gross profit (Q3, 2025)
¥234.6M
Net income (Q3, 2025)
(¥1.7M)
Cash (Q3, 2025)
¥265.7M
EBIT (Q3, 2025)
¥2.8M
Enterprise value
$6.2B

Footer menu